These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32799384)

  • 21. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
    Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
    Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
    Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong.
    Leung CM; Lai LS; Wong WH; Chan KH; Luk YW; Lai JY; Yeung YW; Hui WM
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1786-90. PubMed ID: 19686415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
    PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease.
    Kim D; Vazquez-Montesino LM; Li AA; Cholankeril G; Ahmed A
    Hepatology; 2020 Nov; 72(5):1556-1568. PubMed ID: 32012316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coffee, tea, and lifestyle.
    Schwarz B; Bischof HP; Kunze M
    Prev Med; 1994 May; 23(3):377-84. PubMed ID: 8078860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
    Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
    Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.
    Seto WK; Hui RWH; Mak LY; Fung J; Cheung KS; Liu KSH; Wong DK; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):575-583.e2. PubMed ID: 28970146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity.
    Lahelma M; Luukkonen PK; Qadri S; Ahlholm N; Lallukka-Brück S; Porthan K; Juuti A; Sammalkorpi H; Penttilä AK; Arola J; Orho-Melander M; Yki-Järvinen H
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33429859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-response association between physical activity and non-alcoholic fatty liver disease: a case-control study in a Chinese population.
    Li Y; He F; He Y; Pan X; Wu Y; Hu Z; Lin X; Xu S; Peng XE
    BMJ Open; 2019 Mar; 9(3):e026854. PubMed ID: 30928957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping.
    Hallsworth K; McPherson S; Anstee QM; Flynn D; Haigh L; Avery L
    J Med Internet Res; 2021 Jan; 23(1):e20491. PubMed ID: 33448929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutrition and physical activity in Asian Indians with non-alcoholic fatty liver: A case control study.
    Bhatt SP; Misra A; Nigam P
    Diabetes Metab Syndr; 2019; 13(2):1271-1274. PubMed ID: 31336476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study.
    Lee HW; Wong GL; Kwok R; Choi KC; Chan CK; Shu SS; Leung JK; Chim AM; Luk AO; Ma RC; Chan HL; Chan JC; Kong AP; Wong VW
    Hepatology; 2020 Oct; 72(4):1230-1241. PubMed ID: 31991487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.
    Kwak MS; Kim D
    Korean J Intern Med; 2018 Jan; 33(1):64-74. PubMed ID: 29202557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
    Li C; Guo P; Okekunle AP; Ji X; Huang M; Qi J; Jiang Y; Feng R; Li R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):256-262. PubMed ID: 29949199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease.
    Shalimar ; Kumar R; Rout G; Kumar R; Yadav R; Das P; Aggarwal S; Gunjan D; Saraya A; Nayak B
    Indian J Gastroenterol; 2020 Feb; 39(1):32-41. PubMed ID: 32185692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors.
    Al-Dayyat HM; Rayyan YM; Tayyem RF
    Diabetes Metab Syndr; 2018 Jul; 12(4):569-575. PubMed ID: 29571977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.